DRUG

panitumumab-IRDye800

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for panitumumab-IRDye800

Pancreatic cancer 1

Mediator Outcome Score Tier Lit. status Trial
EGFR pancreatic ductal adenocarcinoma 0.208 Mid novel signal none

Clinical trials

11 registered trials for panitumumab-IRDye800

Source: ClinicalTrials.gov

← All drugs